Acute myeloid leukemia (AML) arises from the clonal expansion of aberrant hematopoietic stem cells, for which early events like CH-associated mutations together with later events like FLT3-ITD, NRAS or NPM1 mutations initiate the disease. Here, FLT3 is linked to acute myeloid leukemia.